Form 4 for RXST RxSight, Inc.
Accepted 2025-08-04 00:00:00 ET · period of report 2025-07-31 · accession 0000950170-25-102098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-04 | 2025-07-31 | RXST | COHEN RAYMOND W | Dir | A - Grant | $0.00 | +35.7K | 35.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-31 | A | A | 35,668 | $0.00 | 35,668 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. (F2) Subject to the Reporting Person's continuing service as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one third of the RSUs subject to the award shall vest on each annual anniversary of July 31, 2025. |